Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$21.0 - $29.1 $6,468 - $8,962
-308 Reduced 0.85%
35,878 $795,000
Q4 2023

Feb 13, 2024

SELL
$19.72 - $28.68 $2,879 - $4,187
-146 Reduced 0.4%
36,186 $995,000
Q3 2023

Nov 13, 2023

BUY
$22.33 - $29.92 $28,850 - $38,656
1,292 Added 3.69%
36,332 $811,000
Q2 2023

Aug 04, 2023

BUY
$20.96 - $26.99 $9,557 - $12,307
456 Added 1.32%
35,040 $892,000
Q1 2023

May 12, 2023

BUY
$20.58 - $27.89 $14,179 - $19,216
689 Added 2.03%
34,584 $771,000
Q4 2022

Feb 10, 2023

SELL
$15.31 - $29.94 $1,898 - $3,712
-124 Reduced 0.36%
33,895 $804,000
Q3 2022

Nov 14, 2022

BUY
$16.58 - $27.9 $7,958 - $13,392
480 Added 1.43%
34,019 $565,000
Q2 2022

Aug 12, 2022

BUY
$15.45 - $29.52 $633 - $1,210
41 Added 0.12%
33,539 $667,000
Q1 2022

May 13, 2022

SELL
$21.94 - $42.51 $51,734 - $100,238
-2,358 Reduced 6.58%
33,498 $924,000
Q4 2021

Feb 11, 2022

SELL
$36.09 - $53.79 $38,724 - $57,716
-1,073 Reduced 2.91%
35,856 $1.48 Million
Q3 2021

Nov 12, 2021

SELL
$35.62 - $52.97 $31,238 - $46,454
-877 Reduced 2.32%
36,929 $1.72 Million
Q2 2021

Aug 13, 2021

SELL
$32.94 - $56.62 $27,010 - $46,428
-820 Reduced 2.12%
37,806 $1.51 Million
Q1 2021

May 07, 2021

BUY
$44.47 - $81.38 $237,247 - $434,162
5,335 Added 16.03%
38,626 $2.08 Million
Q4 2020

Feb 12, 2021

SELL
$32.49 - $61.88 $31,027 - $59,095
-955 Reduced 2.79%
33,291 $1.63 Million
Q3 2020

Nov 04, 2020

BUY
$26.73 - $35.67 $98,206 - $131,051
3,674 Added 12.02%
34,246 $1.11 Million
Q2 2020

Aug 12, 2020

BUY
$19.49 - $28.11 $51,492 - $74,266
2,642 Added 9.46%
30,572 $792,000
Q1 2020

May 04, 2020

SELL
$16.13 - $30.17 $26,033 - $48,694
-1,614 Reduced 5.46%
27,930 $679,000
Q4 2019

Feb 05, 2020

SELL
$20.78 - $29.99 $5,153 - $7,437
-248 Reduced 0.83%
29,544 $825,000
Q3 2019

Nov 08, 2019

BUY
$23.87 - $30.93 $4,057 - $5,258
170 Added 0.57%
29,792 $715,000
Q2 2019

Aug 13, 2019

BUY
$22.1 - $28.56 $255,918 - $330,724
11,580 Added 64.18%
29,622 $845,000
Q1 2019

May 06, 2019

SELL
$12.0 - $25.76 $7,008 - $15,043
-584 Reduced 3.14%
18,042 $451,000
Q4 2018

Feb 13, 2019

SELL
$9.15 - $14.85 $1,335 - $2,168
-146 Reduced 0.78%
18,626 $234,000
Q3 2018

Nov 09, 2018

BUY
$9.55 - $12.64 $28,850 - $38,185
3,021 Added 19.18%
18,772 $179,000
Q2 2018

Aug 08, 2018

BUY
$5.39 - $9.66 $3,293 - $5,902
611 Added 4.04%
15,751 $147,000
Q1 2018

May 07, 2018

SELL
$5.44 - $6.97 $4,433 - $5,680
-815 Reduced 5.11%
15,140 $84,000
Q4 2017

Feb 09, 2018

BUY
$6.05 - $9.37 $459 - $712
76 Added 0.48%
15,955 $104,000
Q3 2017

Nov 09, 2017

BUY
$7.81 - $8.77 $124,014 - $139,258
15,879
15,879 $139,000

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.44B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.